DENTSPLY SIRONA Research and Development Expenses 2010-2024 | XRAY

DENTSPLY SIRONA annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • DENTSPLY SIRONA research and development expenses for the quarter ending March 31, 2024 were $0.042B, a 8.7% decline year-over-year.
  • DENTSPLY SIRONA research and development expenses for the twelve months ending March 31, 2024 were $180M, a 2.86% increase year-over-year.
  • DENTSPLY SIRONA annual research and development expenses for 2023 were $0.184B, a 5.75% increase from 2022.
  • DENTSPLY SIRONA annual research and development expenses for 2022 were $0.174B, a 1.75% increase from 2021.
  • DENTSPLY SIRONA annual research and development expenses for 2021 were $0.171B, a 39.02% increase from 2020.
DENTSPLY SIRONA Annual Research and Development Expenses
(Millions of US $)
2023 $184
2022 $174
2021 $171
2020 $123
2019 $143
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
DENTSPLY SIRONA Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31 $42
2023-12-31 $43
2023-09-30 $46
2023-06-30 $49
2023-03-31 $46
2022-12-31 $43
2022-09-30 $41
2022-06-30 $45
2022-03-31 $45
2021-12-31 $49
2021-09-30 $39
2021-06-30 $43
2021-03-31 $40
2020-12-31 $42
2020-09-30 $29
2020-06-30 $18
2020-03-31 $34
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.868B $3.965B
DENTSPLY SIRONA Inc. is a global leader in the design, development, manufacture and marketing of dental consumables, dental laboratory products, dental specialty products and consumable medical device products. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. The business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.695B 20.11
Becton Dickinson (BDX) United States $68.578B 19.40
West Pharmaceutical Services (WST) United States $25.606B 45.89
Cardinal Health (CAH) United States $23.653B 13.52
Align Technology (ALGN) United States $21.103B 40.74
Cooper (COO) United States $19.458B 29.44
Labcorp (LH) United States $17.974B 15.47
Henry Schein (HSIC) United States $9.571B 17.02
Merit Medical Systems (MMSI) United States $4.866B 26.67
Patterson (PDCO) United States $2.314B 11.09
CONMED (CNMD) United States $2.296B 20.82
STAAR Surgical (STAA) United States $2.120B 81.40
Atrion (ATRI) United States $0.873B 46.62
Lifevantage (LFVN) United States $0.091B 11.74
Pro-Dex (PDEX) United States $0.067B 33.78
Biolase (BIOL) United States $0.005B 0.00